These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7502864)

  • 1. Anti-HSV-1 herpes vaccination by LUPIDON H: preliminary results.
    De Maria A; Tundo P; Romano A; Grima P
    Adv Exp Med Biol; 1995; 371B():1599-600. PubMed ID: 7502864
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection.
    Mastrolorenzo A; Tiradritti L; Salimbeni L; Zuccati G
    Int J STD AIDS; 1995; 6(6):431-5. PubMed ID: 8845402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A killed commercial vaccine against herpes simplex viruses 1 and 2 as an immunocorrective agent in chronic herpetic infection].
    Barinskiĭ IF; Kasparov AA; Lazarenko AA; Alimbarova LM; Davydova AA; Belkina IV; Platonova AL
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):98-102. PubMed ID: 10876868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Item 84--Herpesvirus infections in the child and the immunocompetent adult: cutaneous and mucosal herpes].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A15-21. PubMed ID: 23176837
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical diagnosis of herpetic gingivostomatitis and its treatment with acyclovir.
    Titone L; Romano A; Cascio A; Florena AM; Daniele E
    J Chemother; 1989 Jul; 1(4 Suppl):1115-7. PubMed ID: 16312796
    [No Abstract]   [Full Text] [Related]  

  • 6. Seventeen years of application of herpes vaccines in Bulgaria.
    Dundarov S; Andonov P
    Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches in fighting herpes simplex virus infections.
    Wilson SS; Fakioglu E; Herold BC
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):559-68. PubMed ID: 19485796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of herpes vaccine and acyclovir (ACV) in a rabbit model following intraocular inoculation of herpes simplex virus.
    Narang HK
    J Chemother; 1995 Jun; 7(3):210-5. PubMed ID: 7562016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
    Wade JC; Day LM; Crowley JJ; Meyers JD
    J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes. Vaccines for HSV.
    Stanberry LR
    Dermatol Clin; 1998 Oct; 16(4):811-6, xiv. PubMed ID: 9891686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus vaccine in recurrent herpetic ocular infection.
    Pivetti-Pezzi P; Accorinti M; Colabelli-Gisoldi RA; Pirraglia MP; Sirianni MC
    Cornea; 1999 Jan; 18(1):47-51. PubMed ID: 9894936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Herpes virus. Herpes infections and therapeutic implications].
    Pelissier A; Girard P; Cavaillon JP
    Chir Dent Fr; 1986 Dec; 56(362):27-32. PubMed ID: 3032528
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of mucocutaneous herpes simplex infections.
    Seidlin M; Straus SE
    Clin Dermatol; 1984; 2(2):100-16. PubMed ID: 6085870
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
    Baumann R; Wunderli W; Riess C; Vogt M
    Schweiz Med Wochenschr; 1993 Dec; 123(51-52):2394-400. PubMed ID: 8290931
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vitaherpavac is the first Russian herpes simplex virus vaccine obtained on the Vero B continuous cell line].
    Barkhaleva OA; Ladyzhenskaia IP; Vorob'eva MS; Shalunova NV; Podcherniaeva RIa; Mikhaĭlova GR; Khorosheva TV; Barinskiĭ IF
    Vopr Virusol; 2009; 54(5):33-7. PubMed ID: 19882901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic immunization for recurrent herpes simplex virus infections.
    McKenzie R; Straus SE
    Adv Exp Med Biol; 1996; 394():67-83. PubMed ID: 8815711
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of oro-facial herpes simplex infections with acyclovir: a review.
    Perna JJ; Eskinazi DP
    Oral Surg Oral Med Oral Pathol; 1988 Jun; 65(6):689-92. PubMed ID: 3041335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral acyclovir therapy in recurrent herpes simplex].
    Djawari D
    Z Hautkr; 1986 Nov; 61(22):1629-32, 1637. PubMed ID: 3811459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections with herpes simplex viruses (2).
    Corey L; Spear PG
    N Engl J Med; 1986 Mar; 314(12):749-57. PubMed ID: 3005859
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
    Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
    J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.